Search

everythinglearnresearchcommunity

for

Search:↓

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Hidden fungal infections might cause heart disease and clogged arteries.

Environmental pollutants can damage hair health and cause hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Men with early hair loss may have higher health risks similar to women with PCOS.

Estrogen therapy can reduce skin aging but has cancer risks.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Annurca apple supplement safely increases hair growth and keratin in humans.

Women with PCOS have more emotional and body image issues than healthy women.

Caffeine may help hair growth in hereditary hair loss.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.